“We look forward to working with Denali on the RIPK1 program as we explore the potential of this mechanism in neurologic and inflammatory diseases ... read more
Denali and Sanofi Partner to Develop Potential Treatments for MS, Other Neurological Disorders
Denali and Sanofi Partner to Develop Potential Treatments for MS, Other Neurological Disorders